Cathy S. Harms

Non-Peptide RGD Surrogates Which Mimic a Gly-Asp β-Turn:  Potent Antagonists of Platelet Glycoprotein IIb−IIIa

Matthew J. Fisher, Bruce P. Gunn, Cathy S. Harms et al. · Journal of Medicinal Chemistry · 1997 · 49 citations · Full text

Chemical Biology, Type Ii, Platelet Receptor Gpiib-iiia +18

Biological properties of a kringleless tissue plasminogen activator (t-PA) mutant

H. J. Ehrlich, Nils U. Bang, Sharon Little et al. · Fibrinolysis and Proteolysis · 1987 · 46 citations

Natural Sciences, Molecular Biology, Biological Properties +6

Functional properties of carbohydrate-depleted tissue plasminogen activator

Sheila P. Little, Nils U. Bang, Cathy S. Harms et al. · Biochemistry · 1984 · 42 citations

Functional Properties, Native Tpa, Glycobiology +17

Use of Conformationally Restricted Benzamidines as Arginine Surrogates in the Design of Platelet GPIIb-IIIa Receptor Antagonists

Daniel J. Sall, Ann Arfsten, Jolie Bastian et al. · Journal of Medicinal Chemistry · 1997 · 22 citations · Full text

Pharmacotherapy, Chemical Biology, Pharmaceutical Chemistry +18

Dihydroisoquinolone RGD mimics. Exploration of the aspartate isostere

Matthew J. Fisher, Bruce P. Gunn, Cathy S. Harms et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 11 citations

Medicinal Chemistry, Bioorganic Chemistry, Biochemistry +6